Clinical Efficacy and Safety of Antiviral Drugs in the Extended Use against COVID-19: What We Know So Far

Md. Hossain, Tabassum Jannat, Shejuti Brishty, Urmi Roy, Saikat Mitra, Md. Rafi, Md. Islam, Mst. Nesa, Md. Islam, Talha Emran

Open source

DOI
10.3390/biologics1020016
Published
2021-09-15
Container
Biologics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biologics1020016,
  title = {Clinical Efficacy and Safety of Antiviral Drugs in the Extended Use against COVID-19: What We Know So Far},
  author = {Md. Hossain and Tabassum Jannat and Shejuti Brishty and Urmi Roy and Saikat Mitra and Md. Rafi and Md. Islam and Mst. Nesa and Md. Islam and Talha Emran},
  year = {2021},
  journal = {Biologics},
  doi = {10.3390/biologics1020016},
  url = {https://doi.org/10.3390/biologics1020016}
}

RIS

TY  - JOUR
TI  - Clinical Efficacy and Safety of Antiviral Drugs in the Extended Use against COVID-19: What We Know So Far
AU  - Md. Hossain
AU  - Tabassum Jannat
AU  - Shejuti Brishty
AU  - Urmi Roy
AU  - Saikat Mitra
AU  - Md. Rafi
AU  - Md. Islam
AU  - Mst. Nesa
AU  - Md. Islam
AU  - Talha Emran
PY  - 2021
JO  - Biologics
DO  - 10.3390/biologics1020016
UR  - https://doi.org/10.3390/biologics1020016
ER  - 

APA

Hossain, M., Jannat, T., Brishty, S., Roy, U., Mitra, S., Rafi, M., Islam, M., Nesa, M., Islam, M., & Emran, T. (2021). Clinical Efficacy and Safety of Antiviral Drugs in the Extended Use against COVID-19: What We Know So Far. Biologics. https://doi.org/10.3390/biologics1020016

Source records